Gentamicin

Kathryn Dzintars, Pharm.D., BCPS, Paul A. Pham, Pharm.D.

INDICATIONS

FDA

  1. Serious infections caused by susceptible strains of organism.
    1. With the exception of uncomplicated UTI, aminoglycosides are generally used in combination for serious infections.
  2. Bacterial septicemia, including neonatal sepsis
  3. Skin, bone and soft tissue infections (including burns)
  4. Meningitis (poor penetration)
  5. Urinary tract
  6. Respiratory tract (poor penetration)
  7. Gastrointestinal tract (including peritonitis)
  8. Inflammatory ocular conditions that are steroid-responsive (opthalmic ointment and suspension)

NON-FDA APPROVED USES

  1. Pneumonia, hospital-acquired (in combination with a beta-lactam, beta-lactam/beta-lactamase inhibitor, or a third/fourth-generation cephalosporin)
  2. Intra-abdominal infection (in combination with an agent with Gram-positive and anaerobe coverage)
  3. Enterococcal endocarditis (in combination with ampicillin)
  4. Pelvic inflammatory disease (PID, in combination with clindamycin)
  5. Infections caused by P. aeruginosa (in combination with a beta-lactam, beta-lactam/beta-lactamase inhibitor, or a third/fourth-generation cephalosporin)
  6. Brucella Species

There's more to see -- the rest of this topic is available only to subscribers.

© 2000–2025 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.